BBLGW Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 birž. 2024 @ 23:00):
Our systems believe the stock currently is undervalued by 1.24% compare to its pairs and should correct upwards.

Stats
Dzisiejszy wolumen	143
Średni wolumen	658
Kapitalizacja rynkowa	1.32M
EPS	$-1.310 ( Q1 \| 2024-05-14 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-298.47 (Sector) 42.63 (Industry) 43.86
ATR14	$0 (0.00%)

ABMD 0.00%

AMIX -4.95%

BBLGW -21.85%

BVS 0.52%

COCH 3.06%

DHAI -3.26%

DHAIW -22.93%

DNAY 8.33%

EYES -5.05%

GBS -1.58%

HSCS -1.70%

HSCSW -32.26%

IINNW 1.61%

INVO -3.33%

LFWD 1.26%

MDAI -2.22%

MGRM 3.86%

MXCT -2.00%

NVNOW -32.98%

NXL -42.91%

NXLIW -15.00%

OSA -7.35%

OSAAW -6.40%

PAVMW 105.67%

PAVMZ 0.00%

PETVW 0.00%

QTI 2.21%

QTNT 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-01-17	Walsh Deina H	Buy	12 500	Employee Stock Option
2024-01-17	Frelick Jeff	Buy	25 000	Employee Stock Option
2024-01-08	Gagnon Robert E.	Buy	8	Non-Employee Stock Option
2024-01-08	Gagnon Robert E.	Buy	9	Non-Employee Stock Option
2024-01-08	Gagnon Robert E.	Sell	0	Common Stock

INSIDER POWER
34.04
Last 92 transactions
Buy: 61 917 793 \| Sell: 15 856 455

Korelacja (AI algo v.1.1b): Undervalued: 1.24% $44.04 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Bone Biologics Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Bone Biologics Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-34.01

FY	2023
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-34.01

FY	2022
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$14.62

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

Bone Biologics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Bone Biologics

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.